DOI: 10.1055/s-00025479

Experimental and Clinical Endocrinology & Diabetes Reports

LinksSchließen

Referenz

van der Lely AJ, Bernabeu I, Cap J. et al.
Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.

Eur J Endocrinol 2011;
164: 325-333

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: